Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Oat fiber supplement shows promise for digestion and blood sugar control

NCT ID NCT06739941

Knowledge-focused Sponsor: One Bio Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at how well healthy adults tolerate different doses of an oat fiber supplement called BG-OS. Sixty participants took either 5, 10, or 20 grams daily for several weeks. Researchers tracked digestive symptoms, blood sugar levels after eating white rice, and collected stool and blood samples. The goal was to see if the fiber is easy on the stomach and if it helps control blood sugar spikes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Oat fiber (BG-OS)
What this could lead to
If it works, this could point toward a simple dietary supplement that supports digestive health and helps manage blood sugar spikes after meals.
What could go wrong
This is a small, early-stage study in healthy people, so results may not apply to those with health conditions. The main focus is on tolerability, not proven health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2025

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: Healthy adults aged 18 to 70 years. * Language Proficiency: Able to read and understand English. * Informed Consent: Capable of providing informed consent. * Technology Access: Must have a personal smartphone device. * Able to download an app * Study Commitment: Willing and able to complete all study assessments over a period of up to 7 weeks. Exclusion Criteria: * Technology Access: Lack of a smartphone and/or internet access. * Medical Conditions: Significant abnormal laboratory values (CBC, CMP, or A1C ≥ 6.5%) at screening. Diagnosed with gastrointestinal, digestive, or metabolic diseases, including: Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease Gluten allergy Diabetes Obesity Significant illness, disease, or condition that may interfere with study participation or outcomes, as determined by the principal investigator. * Allergies: Known allergic reactions to any component of the study product or rice challenge product. * Medications: Prescribed medications likely to influence study measures. * Diet and Supplements: Use of fiber supplements within 30 days prior to enrollment or during the study. Major changes in diet or exercise 30 days prior to enrollment or during the study. * Antibiotics Use: Use of antibiotics within 30 days prior to enrollment or during the study. * Pregnancy and Breastfeeding: Pregnant, planning to become pregnant, or currently breastfeeding. * Substance Use: Excessive alcohol use or substance abuse. * Compliance Concerns: Unlikely to comply with the study protocol for any reason, as determined by the principal investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digestive health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

digestive system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digestive health Metabolic health

Contacts and locations

Locations

  • People Science Inc.

    Los Angeles, California, 90034, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.